Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technology evaluation: AVI-4126, AVI BioPharma.

Alick C Stephens1

  • 1Imperial College London, Department of Paediatrics, Faculty of Medicine, 2nd Floor Medical School, St Mary's Campus, Norfolk Place, Paddington London, W2 1PG UK. a.stephens@imperial.ac.uk

Current Opinion in Molecular Therapeutics
|November 13, 2004
PubMed
Summary

AVI BioPharma is developing AVI-4126, an antisense oligonucleotide targeting c-myc mRNA. This novel therapeutic shows potential for treating restenosis, cancer, and polycystic kidney disease and is currently in Phase II clinical trials.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Use of Dual-Cell-Tracker Dye Staining for the Identification and Characterization of Peanut-Specific T-Cell Subsets.

Methods in molecular biology (Clifton, N.J.)·2019
Same author

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy.

The Journal of allergy and clinical immunology·2014
Same author

Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations.

The Journal of allergy and clinical immunology·2014
Same author

IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy.

The Journal of allergy and clinical immunology·2014
Same author

Distribution of peanut protein in the home environment.

The Journal of allergy and clinical immunology·2013
Same author

Peanut protein in household dust is related to household peanut consumption and is biologically active.

The Journal of allergy and clinical immunology·2013

Area of Science:

  • Molecular biology
  • Oligonucleotide therapeutics
  • Oncology
  • Nephrology

Background:

  • Restenosis, cancer, and polycystic kidney disease represent significant unmet medical needs.
  • The c-myc oncogene is frequently dysregulated in various cancers.
  • Antisense oligonucleotide technology offers a targeted approach to gene regulation.

Purpose of the Study:

  • To evaluate the therapeutic potential of AVI-4126, an antisense oligonucleotide targeting c-myc mRNA.
  • To investigate AVI-4126 for the treatment of restenosis, cancer, and polycystic kidney disease.

Main Methods:

  • Development of AVI-4126, a sequence-specific antisense oligonucleotide.
  • Targeting of c-myc messenger RNA (mRNA) for degradation.

Related Experiment Videos

  • Preclinical and clinical evaluation in relevant disease models and patient populations.

    • Main Results:

    • AVI-4126 demonstrates targeted inhibition of c-myc mRNA expression.
    • Preliminary data suggests potential efficacy in preclinical models of target diseases.
    • Phase II clinical trials are ongoing to assess safety and efficacy in humans.

    Conclusions:

    • AVI-4126 represents a promising targeted therapy for c-myc-related conditions.
    • Further clinical investigation is warranted to establish the therapeutic benefit of AVI-4126.
    • Antisense oligonucleotides targeting c-myc hold potential for diverse therapeutic applications.